Commentary
A teenage girl refuses more cancer treatment; her father disagrees
For those who have recurrent disease and now face only experimental options – if they say no, that’s something we really have to listen to very...
Audio
Can a biodegradable brain implant deliver lifesaving cancer meds?
The tumors shrank, and the mice doubled their lifetime, compared with untreated mice.
Commentary
The surprising occupations with higher-than-expected ovarian cancer rates
This is how these types of studies work; they tend to raise more questions than they answer.
News
Higher alcohol consumption linked to early-onset CRC
Compared with light drinking, moderate and heavy drinking were associated with a significantly elevated risk of early-onset CRC.
News
Cardiorespiratory fitness linked to cancer risk, mortality?
“The clinical implications of these findings further emphasize the importance of CRF for possibly reducing cancer incidence and mortality.”
News
Diabetes may short circuit pembrolizumab benefits in NSCLC
"There is an urgent need to validate our findings and explore whether outcomes in these patients can be improved by better glycemic control."
News
Cannabis for cancer symptoms: Perceived or real benefit?
“The study findings indicate that patients with cancer perceived benefits to using cannabis for many symptoms.”
News
CLL combo treatment: Phase-3 study inconclusive
Results of the clinical trial of a CLL drug triplet therapy, presented at ASCO 2023, showed that more data are needed to determine its long-term...
News
FDA approves first gene therapy for hemophilia A
The expensive, one-time, single-dose IV infusion for severe hemophilia A may offer patients years of freedom from infusions.
News
AHA statement addresses equity in cardio-oncology care
Statement says developing personalized cardioprotection strategies that integrate biological, genetic, and social determinant markers is one way...
News
In head and neck cancer, better outcomes seen in patients with overweight
Among 445 patients treated with chemoradiation, those with overweight saw improvements in survival and tumor recurrence, compared with patients...
Article
Updated: Federal Practitioner Submission Guidelines
Federal Practitioner welcomes submission of manuscripts on subjects pertinent to physicians, clinical pharmacists, physician...
News
ESMO helps hematologists assess new cancer drugs
The group’s new study evaluation tool, the ESMO-MCBS:H, is aimed at helping doctors and others determine the benefit of new blood cancer therapies...
News
Colorectal cancer: Younger patients fare worse
Genetic data also showed increased prevalence of certain mutations in early-onset patients.
News
Imaging techniques will revolutionize cancer detection, expert predicts
Jennifer Barton, PhD, and her colleagues are developing an OCT/fluorescence imaging falloposcope that is 0.8 mm in diameter, flexible, and...
News
Study supports new NCCN classification for cutaneous squamous cell carcinoma
The high- and very-high-risk groups in the NCCN guidelines identify SCCs at greatest risk for developing poor outcomes.
Conference Coverage
Multiprong strategy makes clinical trials less White
Only a small percentage of eligible patients participate in clinical trials in the first place, and very few come from racial and ethnic minority...
Conference Coverage
CBSM phone app eases anxiety, depression in cancer patients
Few patients with cancer have access to psycho-oncologic support.
News
FDA approves talazoparib for metastatic prostate cancer
The new approval is based on findings from the randomized, placebo-controlled, phase 3 TALAPRO-2 trial.
News
Breast cancer family history linked to better BC survival
A family history of breast cancer was associated with a lower risk of breast cancer-specific death, after adjustments, a new study finds.
News
T-DXd active in many solid tumors; ‘shift in thinking’
T-DXd is a potential new treatment option for patients with HER2-expressing solid tumors, experts say.
Clinical Topics
Education Center
Featured Multimedia
Digital Edition
Conference Coverage
-
-
Multiprong strategy makes clinical trials less White -
CBSM phone app eases anxiety, depression in cancer patients -
T-DXd active in many solid tumors; ‘shift in thinking’ -
CAR T-cell benefit in lenalidomide-refractory myeloma -
Huge underuse of germline testing for cancer patients -
Reducing risk for thrombosis in patients with lung cancer -
Gilteritinib maintenance reduces relapse in MRD+ AML -
CMML: GM-CSF inhibitor lenzilumab shows early promise -
PV: Novel rusfertide shows ‘impressive’ efficacy
Question 1 of 5
